Probiotic Bacteria in the Prevention and the Treatment of Inflammatory Bowel Disease

  • Fedorak R
  • Demeria D
  • 22

    Readers

    Mendeley users who have this article in their library.
  • 14

    Citations

    Citations of this article.

Abstract

Definitive curative strategies for inflammatory bowel disease remain challenging for physicians and patients. For decades, probiotic organisms have been used in various gastrointestinal diseases. Only recently has comprehension of the pathophysiology of inflammatory bowel disease developed to the point where the significance of the host gastrointestinal microbial population is seen to have marked influence on the initiation and ongoing inflammatory processes of Crohn disease and ulcerative colitis. Well-designed, large randomized controlled trials using probiotics in patients with inflammatory bowel disease are required for probiotics to become mainstream therapy. © 2012 Elsevier Inc.

Author-supplied keywords

  • Crohn disease
  • Inflammatory bowel disease
  • Pouchitis
  • Prebiotics
  • Probiotics
  • Synbiotics
  • Ulcerative colitis

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Richard Fedorak

  • Denny Demeria

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free